Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Bone marrow transplant 1 3
Diffuse large B-cell lymphoma 1 3
Follicular lymphoma 1 3
Multiple myeloma 1 1
Small cell carcinoma (small cell lung cancer) 1 1
Small cell lung cancer 1 0

Show all 7 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
4
Mild
1
None
1

Commonly reported side effects and conditions associated with Etoposide

Side effect Patients
Chest pain 1
Diabetes type 2 1
Fatigue 1
Hair loss 1
Low blood pressure 1

Why patients stopped taking Etoposide

Multiple reasons could be selected

Reason Patients
Course of treatment ended 3
See all 3 patients who've stopped taking Etoposide

Duration

Currently taking Etoposide

Duration Patients
6 months - 1 year 1

Stopped taking Etoposide

Duration Patients
Less than 1 month 2
1 - 6 months 1
Adherence
Adherence Evaluations
Always 5
Usually 0
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 4
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 1

What people switch to and from

Patients started taking Etoposide after stopping:

Treatment Patients
Pemetrexed (Alimta) 1
Last updated:
There are no evaluations for Etoposide.